Skip to main content
SpringerLink
Log in
SpringerLink
Log in

Cellular Cancer Markers

  • Book
  • © 1995

Overview

Editors:
  1. Carleton T. Garrett

    1. Department of Pathology, Medical College of Virginia, Richmond, USA

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  2. Stewart Sell

    1. Department of Pathology and Laboratory Medicine, University of Texas Medical School, Houston, USA

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

Part of the book series: Contemporary Biomedicine (CB, volume 12)

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (17 chapters)

  1. Front Matter

    Pages i-xi
    Download chapter PDF

  2. Clinical Application of Genetic, Oncogenic, and Differentiation Markers of Cancer

    • Stewart Sell, Carleton T. Garrett
    Pages 1-16

  3. ras Proto-Oncogene Activation in Human Malignancy

    • Geoffrey J. Clark, Channing J. Der
    Pages 17-52

  4. C-myc as a Tumor Marker for Primary Human Cancers

    • Taro Shuin
    Pages 53-76

  5. p53 in Human Cancer

    • Jeffrey R. Marks, Andrew M. Davidoff, J. Dirk Iglehart
    Pages 77-110

  6. Oncogenes and Tumor-Suppressor Genes in Gynecological Malignancies

    • Hironobu Sasano, Kiyoshi Ito, Carleton T. Garrett
    Pages 111-138

  7. Genetic Alterations in Colon Cancer

    • Suhail Nasim, Carleton T. Garrett
    Pages 139-189

  8. Genetic Changes in Breast Cancer

    • Daniel S. Liscia, Tiziana Venesio, Amelia Bernardi, Alberto P. M. Cappa, Robert Callahan
    Pages 191-208

  9. Genetic Alterations in Lung Cancer

    • Stephen J. Lemon, Anita L. Sabichi, Michael J. Birrer
    Pages 209-229

  10. Wilms Tumor-Susceptibility Loci

    • Vicki Huff
    Pages 231-255

  11. Non-Hodgkin’s Lymphomas

    • H.-J. Schuurman, S. C. Henzen-Logmans, Ph. M. Kluin
    Pages 257-288

  12. Phenotypic Expression of Hodgkin’s Disease

    • Su-Ming Hsu, Pei-Ling Hsu
    Pages 289-334

  13. Melanoma Markers

    • Paul B. Googe, Martin C. Mihm Jr.
    Pages 335-350

  14. Detection of Minimal Residual Disease (MRD) in Leukemia and Lymphoma

    • Jonathan M. Ben-Ezra
    Pages 351-374

  15. P-Glycoproteins in Tumors

    • William T. Bellamy, Thomas M. Grogan, Ronald S. Weinstein
    Pages 375-391

  16. Genetically Engineered Antitumor Monoclonal Antibodies

    • S. V. S. Kashmiri, Patricia Horan Hand
    Pages 393-432

  17. Targeting Antisense Oligonucleotide Chemotherapy to the Type I Regulatory Subunit of cAMP-Dependent Protein Kinase

    • Yoon Sang Cho-Chung
    Pages 433-454

  18. Summary and Perspective

    • Carleton T. Garrett, Stewart Sell
    Pages 455-477

  19. Back Matter

    Pages 479-484
    Download chapter PDF
Back to top

Keywords

About this book

In Cellular Cancer Markers leading pathologists and physicians review today's most promising cellular cancer markers, an important emerging class of prognostic markers that can be used in the clinical evaluation of cancer patients. The markers reviewed have been chosen because they are biologically relevant to the growth of cells and possess an accurate and reproducible assay for detection. They also are predictors of tumor behavior, are useful in making clinical decisions, and are cost effective.

Cellular Cancer Markers provides a status report for markers of tumor cell activation, proliferation, and longevity that makes possible an informed judgment regarding the value of many newly proposed tumor markers. It also offers insight into the latest approaches to diagnosing cancer and an appreciation of how these marker-based tests can clarify the prognosis of cancer.

Reviews

The editors should be commended for attempting an extensive compilation of information on cancer markers...-New England Journal of Medicine

Editors and Affiliations

  • Department of Pathology, Medical College of Virginia, Richmond, USA

    Carleton T. Garrett

  • Department of Pathology and Laboratory Medicine, University of Texas Medical School, Houston, USA

    Stewart Sell

Bibliographic Information

  • Book Title: Cellular Cancer Markers

  • Editors: Carleton T. Garrett, Stewart Sell

  • Series Title: Contemporary Biomedicine

  • DOI: https://doi.org/10.1007/978-1-4757-2381-6

  • Publisher: Humana Totowa, NJ

  • eBook Packages: Springer Book Archive

  • Copyright Information: Springer Science+Business Media New York 1995

  • Hardcover ISBN: 978-0-89603-210-1Published: 03 March 1995

  • Softcover ISBN: 978-1-61737-000-7Published: 17 September 2011

  • eBook ISBN: 978-1-4757-2381-6Published: 09 March 2013

  • Edition Number: 1

  • Number of Pages: XII, 484

  • Topics: Pathology

Publish with us

Policies and ethics

Back to top

Search

Navigation